Business · 13/05/2004Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Industry on Postmarketing Studies Under the Food and Drug Administration Modernization Act
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on postmarketing studies under the Food and Drug Administration Modernization Act of 1997, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →